Concurrent Investment Advisors »

Crispr Therapeutics shares owned by Concurrent Investment Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Concurrent Investment Advisors from 13F filings

Historical chart of Concurrent Investment Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Concurrent Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Concurrent Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 17k 64.81
2025-06-30 $1.1M 23k 48.64